Sort
59,101 grants matching “hypertension”
Washington Area Comprehensive Sickle Cell Center
$665,705Victor R Gordeuk · Howard University · U54 · FY2008 · HL
Regulation of T cell immune response in Heart Failure with Preserved Ejection Fraction
$665,693Maria Pilar Alcaide Alonso · Tufts University Boston · R01 · FY2023 · HL
CaMKII-mediated Neuroprotection of Retinal Ganglion Cells
$665,665Bo Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · EY
System factors influencing the postpartum transition to primary care for cardiovascular disease risk management among women with hypertensive disorders in pregnancy
$665,637Kimberley Lynn H Geissler · Baystate Medical Center, Inc. · R01 · FY2023 · HL
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
$665,637Jamie L. Jackson · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · NR
Improving Value of Publicly Funded Mental Health Care
$665,625Marcela V Horvitz-Lennon · Rand Corporation · R01 · FY2019 · MH
Development and Validation of Radiation-Free Pediatric Renal Function Quantification
$665,614Shreyas S Vasanawala · Stanford University · R01 · FY2019 · EB
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
$665,501Sterling M McPherson · Washington State University · R01 · FY2020 · AA
A lifecourse approach to women's cardiometabolic and bone health: from fertility to perimenopause
$665,492Emily Oken · Harvard Pilgrim Health Care, Inc. · R01 · FY2021 · HD
Novel interactions of Slo1 channel and Thromboxane A2 receptor in blood vessels
$665,491Ligia G Toro De Stefani · University Of California Los Angeles · R01 · FY2010 · HL
High-throughput cellular genetics to connect noncoding variants to coronary artery disease genes
$665,483Rajat M Gupta · Broad Institute, Inc. · R01 · FY2025 · HL
Renal Dopamine D1 Receptor Function during Oxidative Stress-related Hypertension
$665,405Mustafa F. Lokhandwala · University Of Houston · R01 · FY2018 · HL
The Role of Circadian Periodicity in Human Cardiovascular Disease and Diabetes
$665,377John P Forman · Brigham And Women'S Hospital · R01 · FY2014 · HL
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
$665,332Alexander Egbe · Mayo Clinic Rochester · R01 · FY2025 · HL
DIABETES PREVENTION PROGRAM (DPP)
$665,306University Of Colorado Denver · U01 · FY2000 · DK
Automated detection of microstructural features that have unique protein markers and are prognostic for chronic kidney disease
$665,277Andrew D Rule · Mayo Clinic Rochester · R01 · FY2024 · DK
Brain-Gut Microbiome-Immune Axis in Hypertension
$665,271Mohan K. Raizada · University Of Florida · R01 · FY2017 · HL
Long-term Impact of Fertility Treatment Study
$665,167John Hsu · Massachusetts General Hospital · R01 · FY2017 · HD
Insulin-Like Growth Factor-1 and Atherosclerosis
$665,154Patrice Delafontaine Delafontaine · Tulane University Of Louisiana · R01 · FY2024 · HL
Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations
$665,124Nadia S Islam · New York University School Of Medicine · R01 · FY2024 · MD
Oral Infections and Vascular Disease Epidemiology Study (INVEST)
$665,052Moise Desvarieux · Columbia University Health Sciences · R01 · FY2016 · DE
Functional Testing and Quality of Life in Glaucoma
$665,042Stuart Gardiner · Legacy Emanuel Hospital And Health Center · R01 · FY2024 · EY
Perinatal Pulmonary Hypertension: Developmental Mediators
$665,026Jeffrey R Fineman · University Of California, San Francisco · R01 · FY2013 · HL
Cardiac function as a mechanism for maladaptive brain aging
$665,005Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2017 · AG
iSIPsmarter: An RCT to evaluate the efficacy, reach, and engagement of a technology-based behavioral and health literacy intervention to reduce sugary beverages among rural Appalachian adults
$664,982Jamie Zoellner · University Of Virginia · R01 · FY2024 · MD